Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PFIZER, INC.

(PFE)
  Report
Delayed Nyse  -  04:03 2022-09-27 pm EDT
44.09 USD   +0.59%
05:37pBiohaven Pharmaceutical's Acquisition by Pfizer Likely to Close Oct. 3
MT
10:00aSonnet BioTherapeutics Appoints Ms. Lori McNeill to the Board of Directors and Formalizes the Company's Business Advisory Committee
AQ
06:17aFitch Revises Pfizer's Outlook to Positive; Affirms IDR at 'A'
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Barclays Adjusts Pfizer's Price Target to $52 From $50, Keeps Equalweight Rating

08/01/2022 | 07:35am EDT


© MT Newswires 2022
All news about PFIZER, INC.
05:37pBiohaven Pharmaceutical's Acquisition by Pfizer Likely to Close Oct. 3
MT
10:00aSonnet BioTherapeutics Appoints Ms. Lori McNeill to the Board of Directors and Formaliz..
AQ
06:17aFitch Revises Pfizer's Outlook to Positive; Affirms IDR at 'A'
AQ
09/26Health Care Down as Investors Flee Defensive Sectors -- Health Care Roundup
DJ
09/26Transcript : Pfizer Inc. - Special Call
CI
09/26Pfizer seeks to expand omicron booster to 5- to 11-year-olds
AQ
09/26In 4 Weeks Meet Pfizer, AstraZeneca, DiME & Many More at the Biosensors for Medical Wea..
AQ
09/26What Is DE&I? Why It Matters?
AQ
09/26Capitulation ahead?
MS
09/26Sector Update: Health Care Stocks Mixed Premarket Monday
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 102 B - -
Net income 2022 32 739 M - -
Net cash 2022 10 262 M - -
P/E ratio 2022 7,79x
Yield 2022 3,67%
Capitalization 247 B 247 B -
EV / Sales 2022 2,34x
EV / Sales 2023 2,90x
Nbr of Employees 79 000
Free-Float 59,0%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 44,09 $
Average target price 55,75 $
Spread / Average Target 26,5%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-25.33%245 989
JOHNSON & JOHNSON-3.58%435 655
ELI LILLY AND COMPANY11.32%292 179
ROCHE HOLDING AG-19.31%253 262
ABBVIE INC.4.29%249 673
MERCK & CO., INC.12.00%218 318